MARATTO

article · The Egyptian Journal of Radiology and Nuclear Medicine

A comparative study of color Doppler ultrasonography and transient hepatic elastography (FibroScan) in grading non-alcoholic fatty liver disease patients and assessing hepatic hemodynamics

2026Open accessCairo University

Abstract

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of elevated liver enzymes encountered in the practice of hepatology and an important predisposing factor for chronic liver disease. Fatty infiltration of the liver parenchyma occurs with variable degrees in NAFLD, ranging from simple hepatic steatosis up to cirrhosis, and hepatocellular carcinoma. Purpose The rationale behind the study is to evaluate and compare the hepatic hemodynamic indices measured by ultrasound and Color Doppler to the different quantified degrees of fibrosis and steatosis measured by transient elastography. Results In this cross-sectional study, twenty-eight females (70%) and twelve males (30%) with NAFLD were involved. Fatty liver severity was graded by sonography (sonography steatosis grade) and FibroScan® (S score), and liver fibrosis was graded through FibroScan® (F stage). Changes to the portal, hepatic, and splenic veins were evaluated by color Doppler. A significant association between sonography steatosis grade and F stages ( p < 0.001) was revealed. In addition, a significant association existed between the sonography steatosis grade and the S score ( p < 0.001). Among Color Doppler findings, there were statistically significant differences in mean portal vein resistivity index (RI) among the S score ( p = 0.007) and the sonography steatosis grades ( p = 0.005), and in mean splenic vein RI among the F stages ( p = 0.021) . Conclusion Color Doppler ultrasonography and hepatic transient elastography complement each other in understanding the degree of hepatic parenchymatous and hemodynamic changes, offering useful insights about the severity of the disease, which likely has valuable clinical implications in terms of treatment and follow-up.

Research topics

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Ultrasound Imaging and Elastography

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1186/s43055-026-01706-2

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.